Suzhou Sepax Technologies
688758
Juneway Electronic Technology
301458
Jiujiang Defu Technology
301511
Cubic Digital Technology
300344
Ningbo Shuanglin Auto Parts
300100
CN Stock MarketDetailed Quotes
600518 Kangmei Pharmaceutical
- 2.21
- -0.07-3.07%
Market Closed Jan 10 15:00 CST
30.64BMarket Cap122.78P/E (TTM)
2.30High2.21Low2.44MlotVolume2.28Open2.28Pre Close548.69MTurnover1.79%Turnover Ratio315.71P/E (Static)13.86BShares2.9552wk High4.35P/B30.08BFloat Cap1.6852wk Low2.51Limit Up13.61BShs Float26.28Historical High2.05Limit Down3.95%Amplitude0.00Historical Low--Dividend TTM2.25Avg Price1.55MlotAsk--Div YieldTTM100Lot Size848.34KlotBid
Kangmei Pharmaceutical News
Legal Opinion of Guangdong Cinda Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Kangmei Pharmaceutical Co., Ltd.
Announcement of Resolutions of Kangmei Pharmaceutical\'s 2024 First Extraordinary General Meeting of Shareholders
Kangmei Pharmaceutical Stock Trading Risk Warning Notice
Kangmei Pharmaceutical 2024 First Extraordinary General Meeting of Shareholders Meeting Information
Kangmei Pharmaceutical: Notice of Kangmei Pharmaceutical on Convening the 2024 First Extraordinary General Meeting of Shareholders
Kangmei Pharmaceutical: Kangmei Pharmaceutical\'s announcement on selecting and hiring an accounting firm
Kangmei Pharmaceutical\'s Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Kangmei Pharmaceutical\'s announcement on selecting and hiring an accounting firm
Kangmei Pharmaceutical: Kangmei Pharmaceutical\'s announcement on progress in the execution of subsidiary lawsuits (3)
Kangmei Pharmaceutical\'s announcement on progress in the execution of subsidiary lawsuits (3)
Announcement of Kangmei Pharmaceutical on the appointment of members of the Strategic Committee of the Ninth Board of Directors.
Announcement on the Progress of Litigation and Execution of Subsidiaries by Kangmei Pharmaceutical (2)
Announcement on the progress of litigation execution by a subsidiary of Kangmei Pharmaceutical.
Announcement of Kangmei Pharmaceutical's Revocation of Other Risk Warnings and Suspension of Stock Trading
Review Opinion on the Self-Inspection Report of Kangmei Pharmaceutical Co., Ltd. by Tianzhi International Certified Public Accountants (Special General Partnership).
Report on Self-Inspection of Kangmei Pharmaceutical
Legal Opinion of Guangdong Xinda Law Firm on Kangmei Pharmaceutical Co., Ltd.'s Application for the Cancellation of Other Risk Warnings
Announcement from Kangmei Pharmaceutical regarding the company's application to cancel other risk warnings for stocks.
Kangmei Pharmaceutical's Reply Notice on the Shanghai Stock Exchange's “Information Disclosure and Supervision Work Letter on the 2023 Annual Report of Kangmei Pharmaceutical Co., Ltd.”
Kangmei Pharmaceutical's announcement on receipt of court enforcement ruling
